APA (7th ed.) Citation

Su, H., Huang, L., Xia, W., Tang, D. G., Zhou, J., & Yang, G. (2025). Elimination of docetaxel-induced senescence attenuates malignant progression in RB1-deficient CRPC. Cellular Oncology (2211-3428), 48(6), 2055. https://doi.org/10.1007/s13402-025-01126-w

Chicago Style (17th ed.) Citation

Su, Huilan, Liqun Huang, Wenwen Xia, Dean G. Tang, Jianjun Zhou, and Guosheng Yang. "Elimination of Docetaxel-induced Senescence Attenuates Malignant Progression in RB1-deficient CRPC." Cellular Oncology (2211-3428) 48, no. 6 (2025): 2055. https://doi.org/10.1007/s13402-025-01126-w.

MLA (9th ed.) Citation

Su, Huilan, et al. "Elimination of Docetaxel-induced Senescence Attenuates Malignant Progression in RB1-deficient CRPC." Cellular Oncology (2211-3428), vol. 48, no. 6, 2025, p. 2055, https://doi.org/10.1007/s13402-025-01126-w.